Patent Yard Sign in
Expired Canadian patentCanada

Use of il-4 to enhance the reparative phase of wound healing and repair and to enhance the healing of infected wounds and the wounds of diabetic mammals

CA 2099263 C · Owner: Schering Corporation · Inventors: Sullivan, Lee M.; Schwarz, Martin A.; Bober, Loretta A.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Methods of enhancing the reparative phase of wound healing and repair in a mammal in need of such enhancing by administering to the wound site during the reparative phase an effective amount of IL-4 preferably topically in a collagen gel suffi-, cient for such enhancing. Also claimed are methods for enhancing the healing and repair of infected wounds wounds of diabetic, mammals, and wounds of immunocompromised mammals in which IL-4 is administered to the wound in a therapeutically effective amount.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed January 7, 1992 and granted March 11, 1997. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 7, 2012.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 7, 2014.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 7, 1992
GrantedMarch 11, 1997
Term endedJanuary 7, 2012
Patent numberCA 2099263 C
Classification (IPC)A61K38/20

Timeline

Timeline From CIPO dates

1993199519971999200120032005200720092011Application filedJan 7, 1992Patent grantedMarch 11, 1997Term endedJan 7, 2012

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.